https://scholars.lib.ntu.edu.tw/handle/123456789/582167
標題: | Hepatitis B virus genotype: What should the clinician know? | 作者: | CHUN-JEN LIU JIA-HORNG KAO |
公開日期: | 2007 | 卷: | 6 | 期: | 1 | 起(迄)頁: | 17-23 | 來源出版物: | Current Hepatitis Reports | 摘要: | Eight genotypes (A-H) of hepatitis B virus (HBV) have been identified. The epidemiology of HBV genotypes and their implications for the natural history of disease progression and response to antiviral therapy have become increasingly recognized. This article presents new lines of evidence regarding the clinical relevance of HBV genotypes and proposes important issues to be resolved in the future. Copyright ? 2007 by Current Medicine Group LLC. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-33947422456&doi=10.1007%2fBF02942174&partnerID=40&md5=5f8319f4640981354f801e2c719d76d3 https://scholars.lib.ntu.edu.tw/handle/123456789/582167 |
ISSN: | 1540-3416 | DOI: | 10.1007/BF02942174 | SDG/關鍵字: | adefovir dipivoxil; alpha interferon; alpha2a interferon; alpha2b interferon; antivirus agent; entecavir; hepatitis B surface antigen; hepatitis B(e) antigen; lamivudine; peginterferon; ribavirin; clinical trial; disease course; environmental factor; gene mutation; genotype; hepatitis; hepatitis B; Hepatitis B virus; human; liver cell carcinoma; liver disease; liver failure; meta analysis; pathogenesis; physician; review; single nucleotide polymorphism; systematic review; treatment outcome; treatment response; virus cell interaction |
顯示於: | 臨床醫學研究所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。